ACOD1-mediated lysosomal membrane permeabilization contributes to <i>Mycobacterium tuberculosis</i> –induced macrophage death

Z Ziwei Yang (Department of Microbiology and Immunology, Weill Cornell Medicine) L Li Zhang S Samantha Ottavi (Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill) J Jacob B. Geri (Merck Center for Catalysis at Princeton University) A Andrew Perkowski (Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill) X Xiuju Jiang (Department of Microbiology and Immunology, Weill Cornell Medicine) D Daniel Pfau (Department of Microbiology and Immunology, Weill Cornell Medicine) R Ruslana Bryk J Jeffrey Aubé (Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill) M Matthew Zimmerman (Center for Discovery and Innovation, Hackensack Meridian Health) V Véronique Dartois (Center for Discovery and Innovation, Hackensack Meridian Health) C Carl Nathan (Department of Microbiology and Immunology, Weill Cornell Medicine)

Abstract

Mycobacterium tuberculosis (Mtb) primarily infects macrophages. In vitro without antibiotics, wild-type Mtb hastens death of the macrophages, but the processes leading to rapid cell death are not well understood. Our earlier work indicated that the death of Mtb-infected mouse macrophages in vitro is markedly exacerbated by induction of interferon-β (IFN-β) [L. Zhang et al., J. Exp. Med. 18 , e20200887 (2021)]. Here, we identified a key downstream response to IFN-β in the context of Mtb infection as the massive induction of cis-aconitate decarboxylase (ACOD1), not only in its canonical subcellular localization in mitochondria but also in the cytosol, where it bound to the lysosome-stabilizing protein HSP70. ACOD1’s product, itaconate, protected Mtb-infected macrophages. However, the contrasting and predominant effect of high-level ACOD1 expression was to act in a noncatalytic manner to promote HSP70’s degradation, leading to lysosomal membrane permeabilization (LMP). Mtb-induced macrophage death was markedly diminished by inhibitors of cysteine proteases, consistent with lysosome-mediated cell death. Neither ACOD1 inhibitors nor cysteine protease inhibitors are suitable for potential host-directed therapy (HDT) of tuberculosis. Instead, this work directs attention to how ACOD1 acts nonenzymatically to promote the degradation of HSP70.

Article Details

Volume / Issue Vol. 122, Issue 12
Published March 25, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (12)

Z

Ziwei Yang

Department of Microbiology and Immunology, Weill Cornell Medicine

L

Li Zhang

S

Samantha Ottavi

Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

J

Jacob B. Geri

Merck Center for Catalysis at Princeton University

A

Andrew Perkowski

Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

X

Xiuju Jiang

Department of Microbiology and Immunology, Weill Cornell Medicine

D

Daniel Pfau

Department of Microbiology and Immunology, Weill Cornell Medicine

R

Ruslana Bryk

J

Jeffrey Aubé

Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

M

Matthew Zimmerman

Center for Discovery and Innovation, Hackensack Meridian Health

V

Véronique Dartois

Center for Discovery and Innovation, Hackensack Meridian Health

C

Carl Nathan

Department of Microbiology and Immunology, Weill Cornell Medicine